CandoxatrilatUK 73967

 

作者: &NA;,  

 

期刊: Drugs in R & D  (ADIS Available online 1999)
卷期: Volume 1, issue 4  

页码: 341-342

 

ISSN:1174-5886

 

年代: 1999

 

出版商: ADIS

 

数据来源: ADIS

 

摘要:

&NA;Candoxatrilat (UK 73967) is a neutral endopeptidase inhibitor that is in phase I of development with Pfizer in the USA. Candoxatrilat is the active form of candoxatril. It is also in clinical trials for the treatment of renal failure.

 

点击下载:  PDF (22KB)



返 回